MUC16 and neoplasm: Patients lacking a tumor capsule (Supplementary Figure S3A), or with high HBV-DNA, high CA125, or large tumor diameter (Supplementary Figure S3B–D) had significantly shorter progression-free survival (PFS, log-rank p < 0.001).